NCT02032641

Brief Summary

The purpose of this study is to determine the efficacy of the 1064nm Neodymium yttrium aluminum garnet (Nd:YAG) laser (Laser Genesis, Cutera TM) in the treatment of surgical scar after direct brow lift.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
9

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jun 2013

Typical duration for not_applicable

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2013

Completed
23 days until next milestone

First Submitted

Initial submission to the registry

June 24, 2013

Completed
7 months until next milestone

First Posted

Study publicly available on registry

January 10, 2014

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2015

Completed
1.7 years until next milestone

Results Posted

Study results publicly available

January 27, 2017

Completed
Last Updated

January 27, 2017

Status Verified

January 1, 2017

Enrollment Period

1.9 years

First QC Date

June 24, 2013

Results QC Date

April 5, 2016

Last Update Submit

January 24, 2017

Conditions

Keywords

Non-ablative laserScar revisiondirect brow lift

Outcome Measures

Primary Outcomes (1)

  • Relative Improvement

    Which scar, overall, appears to have improved more from initial to final visit, as rated by blinded examiner of photographs

    1 month after final treatment

Secondary Outcomes (2)

  • Overall Appearance

    10 minutes before first treatment and at the final visit

  • Hair Loss

    within 1 hour after final treatment

Study Arms (2)

Laser Treatment Side

EXPERIMENTAL

Each patient was randomized to have one of two scars treated with Laser Genesis. The treatment was administered by manually scanning the rapidly pulsed laser in an even, painting motion throughout the entire treatment zone. The eyebrow hairs were covered with white tape to prevent inadvertent alopecia. The laser handpiece was oriented perpendicular to the skin at all times, at a distance of 1-2 cm. Patients were instructed throughout to give verbal feedback regarding if the area was "too hot" as an additional safeguard against epidermal damage.

Device: Laser treatment

Control side

NO INTERVENTION

Each patient had a scar which was randomized to not undergo treatments with Laser Genesis, and was used as a control. Patients were not allowed to undergo laser or any other scar treatments with the exception of sun protection for the control scar for the duration of the study.

Interventions

Non-ablative, non-fractional, microsecond-pulsed Nd:YAG laser 500-1000 pulses, 0.3 msec pulse duration, 10-14 J/cm2, 5 mm spot size

Also known as: Laser Genesis, Cutera, 1064 microsecond-pulsed Nd:YAG laser
Laser Treatment Side

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Undergoing or have undergone direct brow lift

You may not qualify if:

  • under 18 years old
  • history of photodermatoses
  • receiving systemic isotretinoin within the preceding 6 months
  • undergoing other scar treatment in the brow area
  • pregnant patients
  • history of adverse outcomes related to non-ablative laser

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Bascom Palmer Eye Institute

Miami, Florida, 33136, United States

Location

Bascom Palmer Eye Institute

Plantation, Florida, 33324, United States

Location

MeSH Terms

Conditions

Cicatrix

Interventions

Laser Therapy

Condition Hierarchy (Ancestors)

FibrosisPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

TherapeuticsAblation TechniquesSurgical Procedures, Operative

Results Point of Contact

Title
Dr. Sara T. Wester
Organization
Bascom Palmer Eye Institute

Study Officials

  • Sara Wester, MD

    University of Miami

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Ophthalmologist

Study Record Dates

First Submitted

June 24, 2013

First Posted

January 10, 2014

Study Start

June 1, 2013

Primary Completion

May 1, 2015

Study Completion

May 1, 2015

Last Updated

January 27, 2017

Results First Posted

January 27, 2017

Record last verified: 2017-01

Data Sharing

IPD Sharing
Will not share

Submitted for publication but no individual participant data released

Locations